MicroRNA networks surrounding APP and amyloid-β metabolism - Implications for Alzheimer's disease

Experimental Neurology

Volumn 235, Issue 2, 2012, Pages 447-454

  Schonrock, Nicole ^a   Matamales, Miriam ^b   Ittner, Lars M ^b   Götz, Jürgen ^b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

secretase; A (amyloid ); Alzheimer; Animal model; APP (amyloid precursor protein); BACE1; MicroRNA; Neurodegeneration; Splicing; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; MESSENGER RNA; MICRORNA; NEUROLEPTIC AGENT; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; BEHAVIOR DISORDER; BRAIN FUNCTION; CEREBROSPINAL FLUID ANALYSIS; DEPRESSION; DRUG APPROVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDBACK SYSTEM; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE REGULATORY NETWORK; GENE SILENCING; HOMEOSTASIS; HUMAN; MULTIGENE FAMILY; NEUROPATHOLOGY; NONHUMAN; OFF LABEL DRUG USE; PARKINSONISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; TRANSCRIPTION REGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS;

EID: 84860381680     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.11.013     Document Type: Review

References (105)

1. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
2. Ballard C., Howard R. Neuroleptic drugs in dementia: benefits and harm. Nat. Rev. Neurosci. 2006, 7:492-500.
3. Ballard C., Hanney M.L., Theodoulou M., Douglas S., McShane R., Kossakowski K., Gill R., Juszczak E., Yu L.M., Jacoby R. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009, 8:151-157.
4. Ballard C.G., Gauthier S., Cummings J.L., Brodaty H., Grossberg G.T., Robert P., Lyketsos C.G. Management of agitation and aggression associated with Alzheimer disease. Nat. Rev. Neurol. 2009, 5:245-255.
5. Ballard C., Gauthier S., Corbett A., Brayne C., Aarsland D., Jones E. Alzheimer's disease. Lancet 2011, 377:1019-1031.
6. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat. Rev. Neurosci. 2008, 9:768-778.
7. Boissonneault V., Plante I., Rivest S., Provost P. MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J. Biol. Chem. 2009, 284:1971-1981.
8. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278. discussion 278-284.
9. Chen F., David D., Ferrari A., Gotz J. Posttranslational modifications of tau - role in human tauopathies and modeling in transgenic animals. Curr. Drug Targets 2004, 5:503-515.
10. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
11. Cogswell J.P., Ward J., Taylor I.A., Waters M., Shi Y., Cannon B., Kelnar K., Kemppainen J., Brown D., Chen C., Prinjha R.K., Richardson J.C., Saunders A.M., Roses A.D., Richards C.A. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 2008, 14:27-41.
12. Cuellar T.L., Davis T.H., Nelson P.T., Loeb G.B., Harfe B.D., Ullian E., McManus M.T. Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5614-5619.
13. da Cruz e Silva O.A., Henriques A.G., Domingues S.C., da Cruz e Silva E.F. Wnt signalling is a relevant pathway contributing to amyloid beta- peptide-mediated neuropathology in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 2010, 9:720-726.
14. David D., Hoerndli F., Gotz J. Functional genomics meets neurodegenerative disorders Part I: transcriptomic and proteomic technology. Prog. Neurobiol. 2005, 76:153-168.
15. David D.C., Ittner L.M., Gehrig P., Nergenau D., Shepherd C., Halliday G., Gotz J. ß-Amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics 2006, 6:6566-6577.
16. Davis T.H., Cuellar T.L., Koch S.M., Barker A.J., Harfe B.D., McManus M.T., Ullian E.M. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J. Neurosci. 2008, 28:4322-4330.
17. Delay C., Calon F., Mathews P., Hebert S.S. Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function. Mol. Neurodegener. 2011, 6:70.
18. Donev R., Newall A., Thome J., Sheer D. A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms. Mol. Psychiatry 2007, 12:681-690.
19. Duursma A.M., Kedde M., Schrier M., Le Sage C., Agami R. miR-148 targets human DNMT3b protein coding region. RNA 2008, 14:872-877.
20. Eckert A., Hauptmann S., Scherping I., Meinhardt J., Rhein V., Drose S., Brandt U., Fandrich M., Muller W.E., Gotz J. Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice. J. Mol. Med. 2008, 86:1255-1267.
21. Eckert A., Hauptmann S., Scherping I., Rhein V., Muller-Spahn F., Gotz J., Muller W.E. Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice. Neurodegener. Dis. 2008, 5:157-159.
22. Fabian M.R., Sonenberg N., Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
23. Fagan A.M., Shaw L.M., Xiong C., Vanderstichele H., Mintun M.A., Trojanowski J.Q., Coart E., Morris J.C., Holtzman D.M. Comparison of analytical platforms for cerebrospinal fluid measures of {beta}-amyloid 1-42, total tau, and P-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch. Neurol. 2011, 68:1137-1144.
24. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., Finch C.E., St Laurent G., Kenny P.J., Wahlestedt C. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 2008, 14:723-730.
25. Forman J.J., Legesse-Miller A., Coller H.A. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14879-14884.
26. Glabe C.G. Structural classification of toxic amyloid oligomers. J. Biol. Chem. 2008, 283:29639-29643.
27. Gotz J., Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. Neurosci. 2008, 9:532-544.
28. Gotz J., Ittner L.M., Schonrock N., Cappai R. An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr. Dis. Treat. 2008, 4:1033-1042.
29. Gotz J., Eckert A., Matamales M., Ittner L.M., Liu X. Modes of Abeta toxicity in Alzheimer's disease. Cell. Mol. Life Sci. 2011, 68:3359-3375.
30. Greenfield J.P., Tsai J., Gouras G.K., Hai B., Thinakaran G., Checler F., Sisodia S.S., Greengard P., Xu H. Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:742-747.
31. Hallbergson A.F., Gnatenco C., Peterson D.A. Neurogenesis and brain injury: managing a renewable resource for repair. J. Clin. Invest. 2003, 112:1128-1133.
32. Hartmann T., Bieger S.C., Bruhl B., Tienari P.J., Ida N., Allsop D., Roberts G.W., Masters C.L., Dotti C.G., Unsicker K., Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med. 1997, 3:1016-1020.
33. Hebert S.S., De Strooper B. Alterations of the microRNA network cause neurodegenerative disease. Trends Neurosci. 2009, 32:199-206.
34. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6415-6420.
35. Hebert S.S., Horre K., Nicolai L., Bergmans B., Papadopoulou A.S., Delacourte A., De Strooper B. MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol. Dis. 2009, 33:422-428.
36. Hebert S.S., Papadopoulou A.S., Smith P., Galas M.C., Planel E., Silahtaroglu A.N., Sergeant N., Buee L., De Strooper B. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum. Mol. Genet. 2010, 19:3959-3969.
37. Hoerndli F.J., Toigo M., Schild A., Gotz J., Day P.J. Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. Anal. Biochem. 2004, 335:30-41.
38. Hoerndli F., David D., Gotz J. Functional genomics meets neurodegenerative disorders. Part II: application and data integration. Prog. Neurobiol. 2005, 76:169-188.
39. Ittner L.M., Gotz J. Amyloid-beta and tau - a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 2011, 12:65-72.
40. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wolfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
41. Jin K., Peel A.L., Mao X.O., Xie L., Cottrell B.A., Henshall D.C., Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:343-347.
42. Jopling C.L., Yi M., Lancaster A.M., Lemon S.M., Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005, 309:1577-1581.
43. Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., Hannon G., Abeliovich A. A MicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
44. Kitazume S., Tachida Y., Kato M., Yamaguchi Y., Honda T., Hashimoto Y., Wada Y., Saito T., Iwata N., Saido T., Taniguchi N. Brain endothelial cells produce amyloid beta from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form. J. Biol. Chem. 2010, 285:40097-40103.
45. Kurosinski P., Gotz J. Glial cells under physiologic and pathological conditions. Arch. Neurol. 2002, 59:1524-1528.
46. Lahiri D.K., Ge Y.W., Maloney B. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell type-specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J. 2005, 19:653-655.
47. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
48. Lau P., de Strooper B. Dysregulated microRNAs in neurodegenerative disorders. Semin. Cell Dev. Biol. 2010, 21:768-773.
49. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., Kim V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23:4051-4060.
50. Leucht C., Stigloher C., Wizenmann A., Klafke R., Folchert A., Bally-Cuif L. MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary. Nat. Neurosci. 2008, 11:641-648.
51. Lewczuk P., Kornhuber J., Vanmechelen E., Peters O., Heuser I., Maier W., Jessen F., Burger K., Hampel H., Frolich L., Henn F., Falkai P., Ruther E., Jahn H., Luckhaus C., Perneczky R., Schmidtke K., Schroder J., Kessler H., Pantel J., Gertz H.J., Vanderstichele H., de Meyer G., Shapiro F., Wolf S., Bibl M., Wiltfang J. Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: a multicenter study with multiplexing. Exp. Neurol. 2010, 223:366-370.
52. Lim Y.-A., Rhein V., Baysang G., Meier F., Poljak A., Raftery M., Ittner L.M., Guilhaus M., Eckert A., Gotz J. Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction. Proteomics 2010, 10:1621-1633.
53. Long J.M., Lahiri D.K. MicroRNA-101 downregulates Alzheimer's amyloid-beta precursor protein levels in human cell cultures and is differentially expressed. Biochem. Biophys. Res. Commun. 2011, 404:889-895.
54. Lukiw W.J. Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 2007, 18:297-300.
55. Makeyev E.V., Zhang J., Carrasco M.A., Maniatis T. The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 2007, 27:435-448.
56. Maloney B., Ge Y.W., Greig N., Lahiri D.K. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease. FASEB J. 2004, 18:1288-1290.
57. Mathonnet G., Fabian M.R., Svitkin Y.V., Parsyan A., Huck L., Murata T., Biffo S., Merrick W.C., Darzynkiewicz E., Pillai R.S., Filipowicz W., Duchaine T.F., Sonenberg N. MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007, 317:1764-1767.
58. Mattick J.S., Makunin I.V. Small regulatory RNAs in mammals. Hum. Mol. Genet. 2005, 14:R121-R132. Spec No 1.
59. Nikolaev A., McLaughlin T., O'Leary D.D., Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009, 457:981-989.
60. Niwa R., Zhou F., Li C., Slack F.J. The expression of the Alzheimer's amyloid precursor protein-like gene is regulated by developmental timing microRNAs and their targets in Caenorhabditis elegans. Dev. Biol. 2008, 315:418-425.
61. Nunez-Iglesias J., Liu C.C., Morgan T.E., Finch C.E., Zhou X.J. Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation. PLoS One 2010, 5:e8898.
62. O'Carroll D., Mecklenbrauker I., Das P.P., Santana A., Koenig U., Enright A.J., Miska E.A., Tarakhovsky A. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 2007, 21:1999-2004.
63. O'Connor T., Sadleir K.R., Maus E., Velliquette R.A., Zhao J., Cole S.L., Eimer W.A., Hitt B., Bembinster L.A., Lammich S., Lichtenthaler S.F., Hebert S.S., De Strooper B., Haass C., Bennett D.A., Vassar R. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 2008, 60:988-1009.
64. Ono K., Condron M.M., Teplow D.B. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14745-14750.
65. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 2008, 30:460-471.
66. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010, 13:812-818.
67. Papagiannakopoulos T., Kosik K.S. MicroRNA-124: micromanager of neurogenesis. Cell Stem. Cell 2009, 4:375-376.
68. Pasic M.D., Diamandis E.P., McLaurin J., Holtzman D.M., Schmitt-Ulms G., Quirion R. Alzheimer disease: advances in pathogenesis, diagnosis, and therapy. Clin. Chem. 2011, 57:664-669.
69. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Muller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
70. Patel N., Hoang D., Miller N., Ansaloni S., Huang Q., Rogers J.T., Lee J.C., Saunders A.J. MicroRNAs can regulate human APP levels. Mol. Neurodegener. 2008, 3:10.
71. Roberson E.D., Scearce-Levie K., Palop J.J., Yan F., Cheng I.H., Wu T., Gerstein H., Yu G.Q., Mucke L. Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 2007, 316:750-754.
72. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 2002, 277:45518-45528.
73. Saito T., Suemoto T., Brouwers N., Sleegers K., Funamoto S., Mihira N., Matsuba Y., Yamada K., Nilsson P., Takano J., Nishimura M., Iwata N., Van Broeckhoven C., Ihara Y., Saido T.C. Potent amyloidogenicity and pathogenicity of Abeta43. Nat. Neurosci. 2011, 14:1023-1032.
74. Sastre M., Steiner H., Fuchs K., Capell A., Multhaup G., Condron M.M., Teplow D.B., Haass C. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep. 2001, 2:835-841.
75. Schaefer A., O'Carroll D., Tan C.L., Hillman D., Sugimori M., Llinas R., Greengard P. Cerebellar neurodegeneration in the absence of microRNAs. J. Exp. Med. 2007, 204:1553-1558.
76. Schipper H.M., Maes O.C., Chertkow H.M., Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Biol. 2007, 1:263-274.
77. Schonrock N., Ke Y.D., Humphreys D., Staufenbiel M., Ittner L.M., Preiss T., Gotz J. Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 2010, 5:e11070.
78. Schonrock N., Humphreys D.T., Preiss T., Gotz J. Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-beta. J Mol Neurosci. 2011, (Jul 1, Electronic publication ahead of print).
79. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
80. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 1997, 275:630-631.
81. Selkoe D.J., Podlisny M.B. Deciphering the genetic basis of Alzheimer's disease. Annu. Rev. Genomics Hum. Genet. 2002, 3:67-99.
82. Shibata M., Kurokawa D., Nakao H., Ohmura T., Aizawa S. MicroRNA-9 modulates Cajal-Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium. J. Neurosci. 2008, 28:10415-10421.
83. Shin D., Shin J.Y., McManus M.T., Ptacek L.J., Fu Y.H. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann. Neurol. 2009, 66:843-857.
84. Shioya M., Obayashi S., Tabunoki H., Arima K., Saito Y., Ishida T., Satoh J. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3. Neuropathol. Appl. Neurobiol. 2010, 36:320-330.
85. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
86. Smith P., Al Hashimi A., Girard J., Delay C., Hebert S.S. In vivo regulation of amyloid precursor protein neuronal splicing by microRNAs. J. Neurochem. 2011, 116:240-247.
87. Tay Y., Zhang J., Thomson A.M., Lim B., Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
88. Tomiyama T., Matsuyama S., Iso H., Umeda T., Takuma H., Ohnishi K., Ishibashi K., Teraoka R., Sakama N., Yamashita T., Nishitsuji K., Ito K., Shimada H., Lambert M.P., Klein W.L., Mori H. A mouse model of amyloid beta oligomers: their contribution to synaptic alteration, abnormal tau phosphorylation, glial activation, and neuronal loss in vivo. J. Neurosci. 2010, 30:4845-4856.
89. Vilardo E., Barbato C., Ciotti M., Cogoni C., Ruberti F. MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J. Biol. Chem. 2010, 285:18344-18351.
90. Wakiyama M., Takimoto K., Ohara O., Yokoyama S. Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes Dev. 2007, 21:1857-1862.
91. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
92. Wang W.X., Rajeev B.W., Stromberg A.J., Ren N., Tang G., Huang Q., Rigoutsos I., Nelson P.T. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 2008, 28:1213-1223.
93. Wang X., Liu P., Zhu H., Xu Y., Ma C., Dai X., Huang L., Liu Y., Zhang L., Qin C. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 2009, 80:268-273.
94. Wang H., Liu J., Zong Y., Xu Y., Deng W., Zhu H., Liu Y., Ma C., Huang L., Zhang L., Qin C. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-beta type II receptor. Brain Res. 2010, 1357:166-174.
95. Wang W.X., Wilfred B.R., Madathil S.K., Tang G., Hu Y., Dimayuga J., Stromberg A.J., Huang Q., Saatman K.E., Nelson P.T. miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am. J. Pathol. 2010, 177:334-345.
96. Weidemann A., Eggert S., Reinhard F.B., Vogel M., Paliga K., Baier G., Masters C.L., Beyreuther K., Evin G. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 2002, 41:2825-2835.
97. Weintraub D., Rosenberg P.B., Drye L.T., Martin B.K., Frangakis C., Mintzer J.E., Porsteinsson A.P., Schneider L.S., Rabins P.V., Munro C.A., Meinert C.L., Lyketsos C.G. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am. J. Geriatr. Psychiatry 2010, 18:332-340.
98. Weyer S.W., Klevanski M., Delekate A., Voikar V., Aydin D., Hick M., Filippov M., Drost N., Schaller K.L., Saar M., Vogt M.A., Gass P., Samanta A., Jaschke A., Korte M., Wolfer D.P., Caldwell J.H., Muller U.C. APP and APLP2 are essential at PNS and CNS synapses for transmission, spatial learning and LTP. EMBO J. 2011, 30:2266-2280.
99. Williams A.H., Valdez G., Moresi V., Qi X., McAnally J., Elliott J.L., Bassel-Duby R., Sanes J.R., Olson E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554.
100. Wilquet V., De Strooper B. Amyloid-beta precursor protein processing in neurodegeneration. Curr. Opin. Neurobiol. 2004, 14:582-588.
101. Xu H., Sweeney D., Wang R., Thinakaran G., Lo A.C., Sisodia S.S., Greengard P., Gandy S. Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3748-3752.
102. Zhang Y.W., Thompson R., Zhang H., Xu H. APP processing in Alzheimer's disease. Mol. Brain 2011, 4:e3.
103. Zhao G., Mao G., Tan J., Dong Y., Cui M.Z., Kim S.H., Xu X. Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein. J. Biol. Chem. 2004, 279:50647-50650.
104. Zhao C., Sun G., Li S., Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 2009, 16:365-371.
105. Zong Y., Wang H., Dong W., Quan X., Zhu H., Xu Y., Huang L., Ma C., Qin C. miR-29c regulates BACE1 protein expression. Brain Res. 2011, 1395:108-115.